# FDA recall D-0175-2023

> **Nephron Sc Inc** · Class II · drug recall initiated 2023-01-13.

## Product

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch,  NDC 0487-2784-01 UPC 3 04872 78401 4

## Reason for recall

Short Fill

## Distribution

Nationwide within the United States including Puerto Rico. Guatamala

## Key facts

- **Recall number:** D-0175-2023
- **Recalling firm:** Nephron Sc Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-01-13
- **Report date:** 2023-02-01
- **Termination date:** 2024-10-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** West Columbia, SC, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0175-2023

## Citation

> AI Analytics. FDA recall D-0175-2023. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0175-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*